Is it time to ReSET the standard for estrogen receptor testing in breast cancer?

MeSH terms

• Antineoplastic Agents, Hormonal / therapeutic use*
• Biomarkers, Tumor / genetics*
• Biomarkers, Tumor / metabolism
• Breast Neoplasms / drug therapy
• Breast Neoplasms / genetics*
• Breast Neoplasms / mortality
• Breast Neoplasms / secondary
• Chemotherapy, Adjuvant
• Disease-Free Survival
• Estrogen Receptor alpha / genetics*
• Estrogen Receptor alpha / metabolism
• Female
• Gene Expression Profiling
• Gene Expression Regulation, Neoplastic*
• Genomics* / methods
• Humans
• Neoplasm Staging
• Oligonucleotide Array Sequence Analysis
• Risk Assessment
• Risk Factors
• Time Factors
• Transcription, Genetic
• Treatment Outcome